Spandan Medtech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17720.95%
- Profit Growth 135.74%
- Ebitda -3240.13%
- Net Worth 7.53%
- Total Assets 436.89%
About Spandan Medtech
Spandan Medtech Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2020 (Four years and two months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjive Kohli, Manthan Kohli, and Mehul Kohli serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2020PTC374537
- Company No.
374537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2020
- Date of AGM
24 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Spandan Medtech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjive Kohli  | Director | 15-Dec-2020 | Current |
| Manthan Kohli | Director | 15-Dec-2020 | Current |
| Mehul Kohli | Director | 24-Aug-2024 | Current |
Financial Performance of Spandan Medtech.
Spandan Medtech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17720.95% increase. The company also saw a substantial improvement in profitability, with a 135.74% increase in profit. The company's net worth moved up by a moderate rise of 7.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spandan Medtech?
Unlock access to Spandan Medtech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spandan Medtech?
Spandan Medtech has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spandan Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spandan Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
